about
Current Status of Hybrid PET/MRI in Oncologic ImagingDiffusion-weighted imaging outside the brain: Consensus statement from an ISMRM-sponsored workshopThe role of MRI in prostate cancer diagnosis and management.Radiology Research in Quality and Safety: Current Trends and Future Needs.The Science of Quality Improvement.Enriched Audience Engagement Through Twitter: Should More Academic Radiology Departments Seize the Opportunity?Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales.Prostate imaging reporting and data system (PI-RADS): reflections on early experience with a standardized interpretation scheme for multiparametric prostate MRI.National specialty trends in billable diagnostic ultrasound in the ED: analysis of Medicare claims data.Minimization of errors in biexponential T2 measurements of the prostate.Prostate Imaging Reporting and Data System (PI-RADS), Version 2: A Critical Look.Application of anatomically accurate, patient-specific 3D printed models from MRI data in urological oncology.Reply to "Standardizing Biparametric MRI to Simplify and Improve Prostate Imaging Reporting and Data System, Version 2, in Prostate Cancer Management".Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessmentMagnetic resonance imaging appearance of ovarian stromal hyperplasia and ovarian hyperthecosis.Methods and challenges in quantitative imaging biomarker developmentClinical utility of quantitative imaging.Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI.MRI phenotype in renal cancer: is it clinically relevant?Comparison of Coregistration Accuracy of Pelvic Structures Between Sequential and Simultaneous Imaging During Hybrid PET/MRI in Patients with Bladder CancerContrast reaction training in US radiology residencies: a COARDRI study.Changing Medicare Utilization of Minimally Invasive Procedures for the Treatment of Chronic Venous Insufficiency.Assessment of change in prostate volume and shape following surgical resection through co-registration of in-vivo MRI and fresh specimen ex-vivo MRI.The Qualified Clinical Data Registry: A Pathway to Success within MACRA.Medicare Claims Data Resources: A Primer for Policy-Focused Radiology Health Services Researchers.Prostate Cancer: Utility of Whole-Lesion Apparent Diffusion Coefficient Metrics for Prediction of Biochemical Recurrence After Radical Prostatectomy.Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy.Prostate tumour volumes: evaluation of the agreement between magnetic resonance imaging and histology using novel co-registration software.Image Guided Focal Therapy for Magnetic Resonance Imaging Visible Prostate Cancer: Defining a 3-Dimensional Treatment Margin Based on Magnetic Resonance Imaging Histology Co-Registration Analysis.Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate CancerPerformance of simultaneous high temporal resolution quantitative perfusion imaging of bladder tumors and conventional multi-phase urography using a novel free-breathing continuously acquired radial compressed-sensing MRI sequenceFree-breathing contrast-enhanced multiphase MRI of the liver using a combination of compressed sensing, parallel imaging, and golden-angle radial sampling.Preliminary experience with a novel method of three-dimensional co-registration of prostate cancer digital histology and in vivo multiparametric MRI.CT and MRI appearance of solitary parapelvic neurofibroma of the kidney.Role of MRI in minimally invasive focal ablative therapy for prostate cancer.Regional variation in medicare imaging utilization and expenditures: 2007-2011 trends and comparison with other health services.Indeterminate liver and renal lesions: comparison of computed tomography and magnetic resonance imaging in providing a definitive diagnosis and impact on recommendations for additional imaging.Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI.Adoption of an integrated radiology reading room within a urologic oncology clinic: initial experience in facilitating clinician consultations.New OPTN/UNOS classification system for nodules in cirrhotic livers detected with MR imaging: effect on hepatocellular carcinoma detection and transplantation allocation.
P50
Q26825265-62E59E0C-DCA1-482D-BCDA-7EFF05BC3831Q28079278-D77C2FBC-82C2-4986-83B7-A19D2ECF488FQ30245245-6B6D3322-DB3E-40E4-82FE-6BE27586CCAEQ30274786-CE5AB6CE-5FEA-4FD0-9635-F08E7E8C9565Q30274788-69D3DB33-433F-42FF-86D6-3DB5ACC18282Q30374716-B838B4D7-EC02-4D66-AF8C-7C6B7BC1B6A9Q30650693-047F0D62-D9F4-4ED7-A633-4FF1B3497D96Q30724271-738A7E76-FC56-4539-9277-F0F06325FD2CQ30857465-B7A84703-1062-4B8C-A902-8E0CF858EB94Q30897579-B79617E2-DFC0-4F80-AD44-2E3FD791F063Q31049070-0F6CEC44-C2CA-47DC-A577-0AFC1D8C87C4Q31059285-E7764299-1479-4782-9A5D-63DDBA484FC5Q31112954-0CF43138-FFD5-41DB-9B7A-EA74BF3B44C1Q34475350-BECCC376-F2AF-4008-97F3-9BF476D86141Q34614226-C64DEB4E-AAD4-4455-8618-C3707F630F0EQ34648114-091474BA-9783-46C9-85BD-BBCABD92D9E5Q34656915-14D2A0CA-4CE2-4932-9586-1EB1CE10197BQ34995373-86EEAE50-4921-491A-897A-E4CD65507F84Q35793032-7CA794BF-176B-42C8-BB82-CDC8571623E2Q35828369-008E0F4C-FAFC-42D8-8DDD-57E99C973F6BQ36313361-B11AAC03-52A0-41F2-B6A2-7367EB43A5D9Q36342564-79D05423-1F58-47BB-91BB-2B53A667277CQ36358497-97B240CD-597D-4436-8BF0-D8E120F06843Q36376068-58A82EAD-5EB1-4833-A00A-3D9C384F64ACQ36388014-4334965F-D435-42EB-AF31-BCB32729538EQ36406333-30E3AF2E-5294-4139-A9AA-C6862930DDDAQ36417640-220893A1-918E-4917-8331-BF10571F24B9Q36465803-152A6FC5-F8E7-41F3-9D97-55C00E0FE2ACQ36501631-62F42EDF-751B-467D-8201-25BE5396583FQ36727030-FC66EBAA-7435-4D93-BFFB-9006AF086C7AQ36977504-031D1D1C-CB87-411B-8FC1-76DDC7F49869Q37324455-9252D266-4C57-46D5-A0E2-CFDE11A1C194Q37447030-BCA47871-4A22-4298-8E24-8F455BC468E6Q37760987-0B37081A-7889-413E-83F2-9D597F5EE90FQ37893860-567521FA-DC09-4456-9EBC-DE96D8C24DB2Q38146016-B7EB9523-6307-4E94-9B09-BA204B4F8AC7Q38165656-C876E883-F329-4896-A241-ADDF79050218Q38173937-10A097F8-2096-4F8C-86DD-68DDF56C7B38Q38184147-E734C806-FF4A-46D5-AE1C-636C55315000Q38258472-BEB5E1A4-F79F-427F-9422-1083213444BA
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Andrew B Rosenkrantz
@en
Andrew B Rosenkrantz
@nl
type
label
Andrew B Rosenkrantz
@en
Andrew B Rosenkrantz
@nl
prefLabel
Andrew B Rosenkrantz
@en
Andrew B Rosenkrantz
@nl
P31
P496
0000-0002-1558-5350